Key Insights

Highlights

Treatment Research

2 treatments under study, led by Labrida Bioclean

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06684769Not ApplicableRecruiting

A Chitosan Brush and Enamel Matrix Derivative for Non-surgical Treatment of Furcations

Showing all 1 trials

Research Network

Common Treatments

  • Labrida Bioclean1
  • Emdogain Fl1

Active Sponsors

  • Labrida AS1
  • University of Oslo1
  • University of Turku1
  • Riga Stradins University1

Top Investigators

Related Conditions

  • Furcation Defects1
  • Periodontitis Adult1
  • Periodontitis Complex1

Activity Timeline